Caroline K. Geiger

Kollektiver Rechtsschutz im Zivilprozess

Caroline K. Geiger

The increased availability of mass-produced goods and the huge amount of services on offer often leads to numerous consumers suffering damages as a result of identical or similar incidents. Caroline Geiger illustrates and analyzes the existing modes of redress in Germany, the …

Variation in the Use of Disease-modifying Therapies in Persons with Multiple Sclerosis by Age (P2-6.002)

Caroline K. Geiger, Rongrong Wang, Carmen Ka Man Ng

To describe differences in MS treatment patterns by age.

Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis

Caroline K. Geiger, Daniel M. Sheinson, Tu My To, David R Jones et autres

BACKGROUND: Non-Hispanic Black and Hispanic persons with MS (pwMS) are more likely to experience rapid disease progression and severe disability than non-Hispanic White pwMS; however, it is unknown how the initiation of high-efficacy disease-modifying therapies (DMTs) differs by race/ethnicity. This real-world study …

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study

Harry Jin, Caroline K. Geiger, Nikki Jessop, Rosetta Pedotti et autres

BACKGROUND: The use and potential benefit of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs) for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in people living with multiple sclerosis (pwMS) remains poorly studied. The objective of this study is …

us, ch (code pays fourni par la source)

Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab

Caroline K. Geiger, Danny Sheinson, Tu My To, D. I. Jones et autres

INTRODUCTION: Prior research has demonstrated that early treatment with high-efficacy disease-modifying therapies (DMTs), including ocrelizumab (OCR), can reduce relapses and delay disease progression among persons with multiple sclerosis (pwMS) compared with escalation from low-/moderate-efficacy DMTs. However, there is a lack of research …

Severity of Symptoms Among Persons With Multiple Sclerosis by PDDS Score (P13-3.011)

Nicole Gidaya Bonine, Caroline K. Geiger, Vanessa Di Felice, Amber R. Salter

Objective: To describe differences in MS symptom severity by PDDS score. Background: The SymptoMScreen was developed to assess the severity of symptoms among persons with multiple sclerosis (pwMS). Patient Determined Disease Steps (PDDS), a self-reported measure of disability, was used as a …

us (code pays fourni par la source)

Declines in Work Productivity in Persons With Multiple Sclerosis by PDDS Score (P13-3.005)

Caroline K. Geiger, Nicole Gidaya Bonine, Vanessa Di Felice, Amber R. Salter

To describe differences in employment status and work productivity by Patient Determined Disease Steps (PDDS) score.

us (code pays fourni par la source)

Trends in postpartum mental health care before and during COVID ‐19

Slawa Rokicki, Maria W. Steenland, Caroline K. Geiger, Rebecca A. Gourevitch et autres

OBJECTIVE: To assess the impact of COVID-19 on trends in postpartum mental health diagnoses and utilization of psychotherapy and prescription drug treatment. DATA SOURCES: Data were obtained from a large, national health insurance claims database that tracks individuals longitudinally. STUDY DESIGN: We …

us (code pays fourni par la source)

Treatment Patterns Among Newly Diagnosed Patients With Multiple Sclerosis by Race and Ethnicity (S40.001)

Caroline K. Geiger, Daniel M. Sheinson, Tu My To, David Jones et autres

To describe treatment patterns among newly diagnosed patients with multiple sclerosis (MS) by race and ethnicity.

Association of Prenatal Care Services, Maternal Morbidity, and Perinatal Mortality With the Advanced Maternal Age Cutoff of 35 Years

Caroline K. Geiger, Mark A. Clapp, Jessica L. Cohen

Importance Maternal and perinatal mortality remain high in the US despite growing rates of prenatal services and spending, and little rigorous evidence exists regarding the impact of prenatal care intensity on pregnancy outcomes. Patients with an expected date of delivery just after …

us (code pays fourni par la source)

Declines in contraceptive visits in the United States during the COVID-19 pandemic

Maria W. Steenland, Caroline K. Geiger, Lucy Chen, Slawa Rokicki et autres

us (code pays fourni par la source)

Association Between Medicaid Prescription Drug Limits and Access to Medications and Health Care Use Among Young Adults With Disabilities

Caroline K. Geiger, Jessica L. Cohen, Benjamin D. Sommers

Importance Prescription drugs are necessary for managing complex physical and mental health conditions for more than 10 million Medicaid beneficiaries with disabilities. However, some state Medicaid programs limit the number of prescription drugs that beneficiaries can obtain monthly, which may decrease access …

us (code pays fourni par la source)